Inst. of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Germany; RWTH Aachen University, Germany; Dept. of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
Inst. of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Germany; Dept. of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
Radiother Oncol. 2022 Jan;166:37-43. doi: 10.1016/j.radonc.2021.11.010. Epub 2021 Nov 18.
Brain metastases show different patterns of contrast enhancement, potentially reflecting hypoxic and necrotic tumor regions with reduced radiosensitivity. An objective evaluation of these patterns might allow a prediction of response to radiotherapy. We therefore investigated the potential of MRI radiomics in comparison with the visual assessment of semantic features to predict early response to stereotactic radiosurgery in patients with brain metastases.
In this retrospective study, 150 patients with 308 brain metastases from solid tumors (NSCLC in 53% of patients) treated by stereotactic radiosurgery (single dose of 17-20 Gy) were evaluated. The response of each metastasis (partial or complete remission vs. stabilization or progression) was assessed within 180 days after radiosurgery. Patterns of contrast enhancement in the pre-treatment T1-weighted MR images were either visually classified (homogenous, heterogeneous, necrotic ring-like) or subjected to a radiomics analysis. Random forest models were optimized by cross-validation and evaluated in a hold-out test data set (30% of metastases).
In total, 221/308 metastases (72%) responded to radiosurgery. The optimal radiomics model comprised 10 features and outperformed the model solely based on semantic features in the test data set (AUC, 0.71 vs. 0.56; accuracy, 69% vs. 54%). The diagnostic performance could be further improved by combining semantic and radiomics features resulting in an AUC of 0.74 and an accuracy of 75% in the test data set.
The developed radiomics model allowed prediction of early response to radiosurgery in patients with brain metastases and outperformed the visual assessment of patterns of contrast enhancement.
脑转移瘤表现出不同的对比增强模式,这可能反映了乏氧和坏死的肿瘤区域,其放射敏感性降低。对这些模式进行客观评估可能有助于预测放疗反应。因此,我们研究了 MRI 放射组学与语义特征的视觉评估相比预测脑转移患者立体定向放射外科治疗早期反应的潜力。
在这项回顾性研究中,评估了 150 例来自实体瘤(53%的患者为非小细胞肺癌)的 308 个脑转移瘤患者,这些患者接受了立体定向放射外科治疗(单次剂量为 17-20Gy)。在放射外科治疗后 180 天内评估每个转移灶的反应(部分或完全缓解与稳定或进展)。在治疗前 T1 加权磁共振图像中,通过视觉分类(均匀、不均匀、坏死环状)或放射组学分析对对比增强模式进行分类。通过交叉验证优化随机森林模型,并在验证集(30%的转移灶)中进行评估。
总共 221/308 个转移灶(72%)对放射外科治疗有反应。最佳放射组学模型包含 10 个特征,在验证集(AUC,0.71 对 0.56;准确性,69% 对 54%)中的表现优于仅基于语义特征的模型。通过结合语义和放射组学特征,可进一步提高诊断性能,在验证集中 AUC 为 0.74,准确性为 75%。
所开发的放射组学模型可预测脑转移患者放射外科治疗的早期反应,且优于对比增强模式的视觉评估。